Hikma Pharmaceuticals PLC Stock

Hikma Pharmaceuticals PLC engages in the development, manufacture, and marketing of generic and in-licensed pharmaceutical products in solid, semi-solid, liquid, and injectable final dosage forms. The company operates primarily in the United States, Europe, the Middle East, and North Africa.

Segments

The company operates in three segments: Branded Pharmaceuticals, Generic Pharmaceuticals, and Injectable Pharmaceuticals.

Branded

The Branded Pharmaceuticals segment develops, manufactures, and markets 241 solid, semi-solid, and liquid branded pharmaceutical products in 460 dosage strengths and forms, including 33 patented products under-license from the originator.

Generics

The Generic Pharmaceuticals segment develops, manufactures, and markets 47 non-branded generic pharmaceutical products in 105 dosage strengths and forms.

Injectables

The Injectable Pharmaceuticals segment develops, manufactures, and markets 81 injectable products in 202 dosage strengths and forms with a focus on anti-infectives, oncology, central nervous system, and cardiology areas.

History

Hikma Pharmaceuticals PLC was founded in 1978.